Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in Int J Hematol

Retrieve available abstracts of 154 articles:
HTML format
Text format



Single Articles


    May 2018
  1. KAWAI H, Matsushita H, Aoyama Y, Matsui K, et al
    Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene.
    Int J Hematol. 2018 May 9. pii: 10.1007/s12185-018-2469.
    PubMed     Text format    


  2. GOTOH N, Saitoh T, Takahashi N, Kasamatsu T, et al
    Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.
    Int J Hematol. 2018 May 8. pii: 10.1007/s12185-018-2464.
    PubMed     Text format     Abstract available


    April 2018
  3. NOGUCHI S, Nakaseko C, Nishiwaki K, Ogasawara H, et al
    Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.
    Int J Hematol. 2018 Apr 30. pii: 10.1007/s12185-018-2459.
    PubMed     Text format     Abstract available


  4. TORIYAMA E, Imaizumi Y, Taniguchi H, Taguchi J, et al
    EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphoma.
    Int J Hematol. 2018 Apr 12. pii: 10.1007/s12185-018-2455.
    PubMed     Text format     Abstract available


    March 2018
  5. WATANABE J, Sato K, Osawa Y, Horiuchi T, et al
    CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
    Int J Hematol. 2018 Mar 29. pii: 10.1007/s12185-018-2436.
    PubMed     Text format     Abstract available


  6. TAKAHASHI H, Kajiwara R, Kato M, Hasegawa D, et al
    Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.
    Int J Hematol. 2018 Mar 27. pii: 10.1007/s12185-018-2440.
    PubMed     Text format     Abstract available


  7. IMAMURA T, Taga T, Takagi M, Kawasaki H, et al
    Nationwide survey of therapy-related leukemia in childhood in Japan.
    Int J Hematol. 2018 Mar 24. pii: 10.1007/s12185-018-2439.
    PubMed     Text format     Abstract available


  8. SANO H, Kobayashi R, Suzuki D, Hori D, et al
    Impact of the D-index deduced from duration and intensity of neutropenia following chemotherapy on the risk of invasive fungal infection in pediatric acute myeloid leukemia.
    Int J Hematol. 2018 Mar 21. pii: 10.1007/s12185-018-2433.
    PubMed     Text format     Abstract available


  9. SANO H, Mochizuki K, Kobayashi S, Ohara Y, et al
    T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia.
    Int J Hematol. 2018 Mar 5. pii: 10.1007/s12185-018-2423.
    PubMed     Text format     Abstract available


  10. MIYOSHI H, Ohshima K
    Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia/lymphoma in Japan.
    Int J Hematol. 2018 Mar 3. pii: 10.1007/s12185-018-2430.
    PubMed     Text format     Abstract available


    February 2018
  11. SUEMATSU M, Imamura T, Chiyonobu T, Osone S, et al
    Lumbosacral polyradiculopathy after intrathecal chemotherapy in pediatric acute lymphoblastic leukemia.
    Int J Hematol. 2018 Feb 22. pii: 10.1007/s12185-018-2427.
    PubMed     Text format    


  12. NAQVI K, Cortes JE, Luthra R, O'Brien S, et al
    Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations.
    Int J Hematol. 2018 Feb 20. pii: 10.1007/s12185-018-2422.
    PubMed     Text format     Abstract available


  13. SATO S, Itonaga H, Taguchi M, Sawayama Y, et al
    Clonal dynamics in a case of acute monoblastic leukemia that later developed myeloproliferative neoplasm.
    Int J Hematol. 2018 Feb 7. pii: 10.1007/s12185-018-2419.
    PubMed     Text format     Abstract available


    January 2018
  14. TAKAMI A
    Hematopoietic stem cell transplantation for acute myeloid leukemia.
    Int J Hematol. 2018 Jan 27. pii: 10.1007/s12185-018-2412.
    PubMed     Text format     Abstract available


  15. SHIMADA A, Iijima-Yamashita Y, Tawa A, Tomizawa D, et al
    Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study.
    Int J Hematol. 2018 Jan 12. pii: 10.1007/s12185-017-2395.
    PubMed     Text format     Abstract available


    December 2017
  16. ABE A, Yamamoto Y, Katsumi A, Okamoto A, et al
    Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).
    Int J Hematol. 2017 Dec 20. pii: 10.1007/s12185-017-2387.
    PubMed     Text format     Abstract available


  17. MIYAMOTO T, Nagafuji K, Fujisaki T, Uchida N, et al
    Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.
    Int J Hematol. 2017 Dec 14. pii: 10.1007/s12185-017-2389.
    PubMed     Text format     Abstract available


  18. SUZUKI D, Kobayashi R, Sano H, Hori D, et al
    Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance.
    Int J Hematol. 2017 Dec 12. pii: 10.1007/s12185-017-2388.
    PubMed     Text format     Abstract available


    November 2017
  19. FUJIMAKI K, Hattori Y, Nakajima H
    10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.
    Int J Hematol. 2017 Nov 29. pii: 10.1007/s12185-017-2382.
    PubMed     Text format     Abstract available


  20. KIKUCHI J, Kuroda Y, Koyama D, Furukawa Y, et al
    Cell adhesion-induced phosphorylation and inactivation of EZH2 confer drug resistance to acute myeloid leukemia cells.
    Int J Hematol. 2017 Nov 28. pii: 10.1007/s12185-017-2376.
    PubMed     Text format    


  21. FUJIWARA SI, Shirato Y, Ikeda T, Kawaguchi SI, et al
    Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia.
    Int J Hematol. 2017 Nov 28. pii: 10.1007/s12185-017-2378.
    PubMed     Text format     Abstract available


  22. YAMAMOTO M, Hori T, Igarashi K, Iesato K, et al
    Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Int J Hematol. 2017 Nov 27. pii: 10.1007/s12185-017-2377.
    PubMed     Text format    


  23. UEMURA S, Nishimura N, Hasegawa D, Shono A, et al
    ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.
    Int J Hematol. 2017 Nov 24. pii: 10.1007/s12185-017-2371.
    PubMed     Text format     Abstract available


    October 2017
  24. COOK LB, Rowan AG, Demontis MA, Sagawe S, et al
    Long-term clinical remission maintained after cessation of zidovudine and interferon-alpha therapy in chronic adult T-cell leukemia/lymphoma.
    Int J Hematol. 2017 Oct 31. doi: 10.1007/s12185-017-2361.
    PubMed     Text format     Abstract available


  25. NAKAMAE H, Fukuda T, Nakaseko C, Kanda Y, et al
    Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial.
    Int J Hematol. 2017 Oct 26. doi: 10.1007/s12185-017-2353.
    PubMed     Text format     Abstract available


  26. TAKEUCHI J, Kusumoto S, Akiyama H, Kanda Y, et al
    JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL).
    Int J Hematol. 2017 Oct 24. doi: 10.1007/s12185-017-2350.
    PubMed     Text format    


  27. HONG CR, Kang HJ, Park KD, Shin HY, et al
    High-dose chemotherapy and autologous peripheral blood stem cell transplantation with BCVAC regimen followed by maintenance chemotherapy for children with very high risk acute lymphoblastic leukemia.
    Int J Hematol. 2017 Oct 20. doi: 10.1007/s12185-017-2355.
    PubMed     Text format     Abstract available


  28. KOZAKAI T, Takahashi M, Higuchi M, Hara T, et al
    MAGI-1 expression is decreased in several types of human T-cell leukemia cell lines, including adult T-cell leukemia.
    Int J Hematol. 2017 Oct 17. doi: 10.1007/s12185-017-2359.
    PubMed     Text format     Abstract available


  29. KOBAYASHI N, Shimizu H, Hirato J, Handa H, et al
    Collision of metastatic malignant melanoma and acute myelogenous leukemia in the bone marrow.
    Int J Hematol. 2017 Oct 17. doi: 10.1007/s12185-017-2356.
    PubMed     Text format    


  30. OKADA Y, Sato K, Kobayashi S, Nagao S, et al
    Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achieved.
    Int J Hematol. 2017 Oct 14. doi: 10.1007/s12185-017-2354.
    PubMed     Text format     Abstract available


  31. ISHIDA T, Akagawa N, Miyata T, Tominaga N, et al
    Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.
    Int J Hematol. 2017 Oct 13. doi: 10.1007/s12185-017-2339.
    PubMed     Text format     Abstract available


  32. WANG Y, Xing Y, Chen L, Meng T, et al
    Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis.
    Int J Hematol. 2017 Oct 13. doi: 10.1007/s12185-017-2342.
    PubMed     Text format     Abstract available


  33. USUI N
    Correction to: JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN).
    Int J Hematol. 2017 Oct 12. doi: 10.1007/s12185-017-2351.
    PubMed     Text format     Abstract available


  34. KUWATSUKA Y, Tomizawa D, Kihara R, Nagata Y, et al
    Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.
    Int J Hematol. 2017 Oct 12. doi: 10.1007/s12185-017-2340.
    PubMed     Text format     Abstract available


    September 2017
  35. USUI N
    JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN).
    Int J Hematol. 2017 Sep 21. doi: 10.1007/s12185-017-2330.
    PubMed     Text format    


  36. TAKAHASHI N, Tauchi T, Kitamura K, Miyamura K, et al
    Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.
    Int J Hematol. 2017 Sep 19. doi: 10.1007/s12185-017-2334.
    PubMed     Text format     Abstract available


  37. KOBAYASHI Y, Munakata W, Ogura M, Uchida T, et al
    Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Int J Hematol. 2017 Sep 13. doi: 10.1007/s12185-017-2327.
    PubMed     Text format     Abstract available


  38. DELIA D, Mizutani S
    The DNA damage response pathway in normal hematopoiesis and malignancies.
    Int J Hematol. 2017;106:328-334.
    PubMed     Text format     Abstract available


    August 2017
  39. ASOU N, Fujita H, Shinagawa K
    JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia: 2. Acute promyelocytic leukemia (APL).
    Int J Hematol. 2017 Aug 30. doi: 10.1007/s12185-017-2318.
    PubMed     Text format    


  40. KOTAKI R, Higuchi H, Ogiya D, Katahira Y, et al
    Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.
    Int J Hematol. 2017 Aug 22. doi: 10.1007/s12185-017-2314.
    PubMed     Text format     Abstract available


  41. HAN DM, Zheng XL, Ding L, Yan HM, et al
    Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia.
    Int J Hematol. 2017 Aug 20. doi: 10.1007/s12185-017-2317.
    PubMed     Text format     Abstract available


  42. HARA R, Onizuka M, Matsusita E, Kikkawa E, et al
    NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.
    Int J Hematol. 2017 Aug 9. doi: 10.1007/s12185-017-2294.
    PubMed     Text format     Abstract available


  43. MIYAWAKI S
    JSH guideline for tumors of hematopoietic and lymphoid tissues: leukemia 1. Acute myeloid leukemia (AML).
    Int J Hematol. 2017 Aug 7. doi: 10.1007/s12185-017-2303.
    PubMed     Text format    


  44. FEURSTEIN S, Godley LA
    Germline ETV6 mutations and predisposition to hematological malignancies.
    Int J Hematol. 2017;106:189-195.
    PubMed     Text format     Abstract available


  45. CHEAH JJC, Hahn CN, Hiwase DK, Scott HS, et al
    Myeloid neoplasms with germline DDX41 mutation.
    Int J Hematol. 2017;106:163-174.
    PubMed     Text format     Abstract available


  46. HAYASHI Y, Harada Y, Huang G, Harada H, et al
    Myeloid neoplasms with germ line RUNX1 mutation.
    Int J Hematol. 2017;106:183-188.
    PubMed     Text format     Abstract available


  47. HUA Y, Wang C, Jiang H, Wang Y, et al
    Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.
    Int J Hematol. 2017;106:248-257.
    PubMed     Text format     Abstract available


    July 2017
  48. GEYER JT, Mathew S
    Myelomonocytic leukemia with intracytoplasmic crystalline inclusions, double minute chromosomes and MYC amplification.
    Int J Hematol. 2017 Jul 28. doi: 10.1007/s12185-017-2299.
    PubMed     Text format    


  49. DI IANNI M, Olioso P, Giancola R, Santarone S, et al
    Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.
    Int J Hematol. 2017 Jul 18. doi: 10.1007/s12185-017-2292.
    PubMed     Text format     Abstract available


  50. REA D, Cayuela JM
    Treatment-free remission in patients with chronic myeloid leukemia.
    Int J Hematol. 2017 Jul 8. doi: 10.1007/s12185-017-2295.
    PubMed     Text format     Abstract available


  51. HIRANO M, Ohno N, Tanosaki R, Mochizuki M, et al
    Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood-ocular barrier.
    Int J Hematol. 2017 Jul 4. doi: 10.1007/s12185-017-2293.
    PubMed     Text format     Abstract available


  52. MIYAZAKI Y
    JSH Guideline for Tumors of Hematopoietic and Lymphoid Tissues: Leukemia: 6. Myelodysplastic syndromes (MDS).
    Int J Hematol. 2017 Jul 4. doi: 10.1007/s12185-017-2272.
    PubMed     Text format    


  53. UEMURA S, Tamura A, Saito A, Hasegawa D, et al
    Reemergence of translocation t(11;19)(q23;p13.1) in the absence of clinically overt leukemia.
    Int J Hematol. 2017 Jul 1. doi: 10.1007/s12185-017-2289.
    PubMed     Text format     Abstract available


  54. KUNIMOTO H, Nakajima H
    Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Int J Hematol. 2017;106:34-44.
    PubMed     Text format     Abstract available


  55. KARIGANE D, Takubo K
    Metabolic regulation of hematopoietic and leukemic stem/progenitor cells under homeostatic and stress conditions.
    Int J Hematol. 2017;106:18-26.
    PubMed     Text format     Abstract available


  56. MATSUO H, Shiga S, Imai T, Kamikubo Y, et al
    Purification of leukemic blast cells from blood smears using laser microdissection.
    Int J Hematol. 2017;106:55-59.
    PubMed     Text format     Abstract available


    June 2017
  57. TANG S, Shen H, Mao X, Dai H, et al
    FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2017 Jun 14. doi: 10.1007/s12185-017-2256.
    PubMed     Text format     Abstract available


  58. ISHITSUKA K, Yurimoto S, Kawamura K, Tsuji Y, et al
    Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: interim results of postmarketing all-case surveillance.
    Int J Hematol. 2017 Jun 9. doi: 10.1007/s12185-017-2270.
    PubMed     Text format     Abstract available


  59. ZHANG R, Chen J, Huang H, Ma J, et al
    Erratum to: Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    Int J Hematol. 2017 Jun 2. doi: 10.1007/s12185-017-2269.
    PubMed     Text format    


  60. ITZYKSON R, Duchmann M, Lucas N, Solary E, et al
    CMML: Clinical and molecular aspects.
    Int J Hematol. 2017;105:711-719.
    PubMed     Text format     Abstract available


    May 2017
  61. TAMURA A, Uemura S, Saito A, Okubo S, et al
    Congenital immature pure erythroid leukemia with E-cadherin expression.
    Int J Hematol. 2017 May 18. doi: 10.1007/s12185-017-2248.
    PubMed     Text format     Abstract available


  62. MINAKATA D, Fujiwara SI, Ikeda T, Toda Y, et al
    Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia.
    Int J Hematol. 2017 May 15. doi: 10.1007/s12185-017-2251.
    PubMed     Text format     Abstract available


  63. HANEKAMP D, Cloos J, Schuurhuis GJ
    Leukemic stem cells: identification and clinical application.
    Int J Hematol. 2017;105:549-557.
    PubMed     Text format     Abstract available


  64. TAKAGI M, Ishiwata Y, Aoki Y, Miyamoto S, et al
    HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.
    Int J Hematol. 2017;105:686-691.
    PubMed     Text format     Abstract available


  65. CAMACHO V, McClearn V, Patel S, Welner RS, et al
    Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.
    Int J Hematol. 2017;105:566-577.
    PubMed     Text format     Abstract available


  66. IKEGAME K, Kaida K, Yoshihara S, Yoshihara K, et al
    Spousal hematopoietic stem cell transplantation.
    Int J Hematol. 2017;105:646-657.
    PubMed     Text format     Abstract available


  67. URESHINO H, Kizuka H, Kusaba K, Sano H, et al
    5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Int J Hematol. 2017;105:692-696.
    PubMed     Text format     Abstract available


    April 2017
  68. TOJO A, Kyo T, Yamamoto K, Nakamae H, et al
    Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study.
    Int J Hematol. 2017 Apr 25. doi: 10.1007/s12185-017-2238.
    PubMed     Text format     Abstract available


  69. HATAKE K, Ogura M, Takada K, Taniwaki M, et al
    Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan.
    Int J Hematol. 2017 Apr 18. doi: 10.1007/s12185-017-2233.
    PubMed     Text format     Abstract available


  70. KE S, Li RC, Lu J, Meng FK, et al
    MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
    Int J Hematol. 2017 Apr 13. doi: 10.1007/s12185-017-2232.
    PubMed     Text format     Abstract available


  71. TAKAHASHI N, Nakaseko C, Kobayashi Y, Miyamura K, et al
    Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment.
    Int J Hematol. 2017 Apr 13. doi: 10.1007/s12185-017-2239.
    PubMed     Text format     Abstract available


  72. IGUCHI A, Cho Y, Sugiyama M, Terashita Y, et al
    Bortezomib combined with standard induction chemotherapy in Japanese children with refractory acute lymphoblastic leukemia.
    Int J Hematol. 2017 Apr 11. doi: 10.1007/s12185-017-2235.
    PubMed     Text format     Abstract available


  73. ONG SY, Ho LP, Yeo PM, Ng HJ, et al
    Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21).
    Int J Hematol. 2017 Apr 7. doi: 10.1007/s12185-017-2230.
    PubMed     Text format    


  74. ZHANG R, Chen J, Huang H, Ma J, et al
    Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study.
    Int J Hematol. 2017 Apr 7. doi: 10.1007/s12185-017-2224.
    PubMed     Text format     Abstract available


  75. SUH KJ, Lee JY, Shin DY, Koh Y, et al
    Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2225.
    PubMed     Text format     Abstract available


  76. YAGUCHI A, Ishibashi T, Terada K, Ueno-Yokohata H, et al
    EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.
    Int J Hematol. 2017 Apr 4. doi: 10.1007/s12185-017-2220.
    PubMed     Text format     Abstract available


  77. ASANO M, Umezu T, Katagiri S, Kobayashi C, et al
    Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors.
    Int J Hematol. 2017;105:419-422.
    PubMed     Text format     Abstract available


    March 2017
  78. NAKAMAE H, Fujisawa S, Ogura M, Uchida T, et al
    Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report.
    Int J Hematol. 2017 Mar 24. doi: 10.1007/s12185-017-2208.
    PubMed     Text format     Abstract available


  79. BARAKA A, Sherief LM, Kamal NM, Shorbagy SE, et al
    Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2206.
    PubMed     Text format     Abstract available


  80. KATZ BZ, Herishanu Y
    Fragility of sub-cellular structures in chronic lymphocytic leukemia.
    Int J Hematol. 2017 Mar 21. doi: 10.1007/s12185-017-2218.
    PubMed     Text format    


  81. ISHIHARA T, Nogami K, Matsumoto T, Nomura A, et al
    Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation.
    Int J Hematol. 2017 Mar 16. doi: 10.1007/s12185-017-2213.
    PubMed     Text format     Abstract available


  82. HASSAN IB, Zaabi MR, Alam A, Hashim MJ, et al
    Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE).
    Int J Hematol. 2017 Mar 14. doi: 10.1007/s12185-017-2211.
    PubMed     Text format     Abstract available


  83. LOVATO S, Ayto R
    Haemolysis in female patient with chronic phase CML.
    Int J Hematol. 2017;105:233-234.
    PubMed     Text format    


  84. KANAMITSU K, Shimada A, Nishiuchi R, Shigemura T, et al
    Pediatric intestinal Behcet disease complicated by myeloid malignancies.
    Int J Hematol. 2017;105:377-382.
    PubMed     Text format     Abstract available


    February 2017
  85. MOLTENI A, Riva M, Ravano E, Marbello L, et al
    Clofarabine-based chemotherapy as a bridge to transplant in the setting of refractory or relapsed acute myeloid leukemia, after at least one previous unsuccessful salvage treatment containing fludarabine: a single institution experience.
    Int J Hematol. 2017 Feb 20. doi: 10.1007/s12185-017-2198.
    PubMed     Text format     Abstract available


  86. SHIGEMATSU A, Kako S, Mitsuhashi K, Iwato K, et al
    Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Int J Hematol. 2017 Feb 14. doi: 10.1007/s12185-017-2197.
    PubMed     Text format     Abstract available


  87. IWASA M, Miura Y, Fujishiro A, Fujii S, et al
    Erratum to: Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Int J Hematol. 2017 Feb 9. doi: 10.1007/s12185-017-2182.
    PubMed     Text format    


  88. YOKOYAMA H, Takahashi N, Katsuoka Y, Inomata M, et al
    Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum.
    Int J Hematol. 2017 Feb 7. doi: 10.1007/s12185-017-2190.
    PubMed     Text format     Abstract available


  89. OGAWA Y, Izutsu K, Kiguchi T, Choi I, et al
    A multicenter, single-arm, Phase II clinical trial of bendamustine monotherapy in patients with chronic lymphocytic leukemia in Japan.
    Int J Hematol. 2017 Feb 3. doi: 10.1007/s12185-016-2178.
    PubMed     Text format     Abstract available


    January 2017
  90. REYNA-FIGUEROA J, Lagunas-Martinez A, Galindo-Delgado P, Fernandez-Bautista MF, et al
    Serum concentrations of apoptosis-associated molecules in septic children with leukemia, neutropenia and fever.
    Int J Hematol. 2017 Jan 31. doi: 10.1007/s12185-016-2175.
    PubMed     Text format     Abstract available


  91. OKSENHENDLER E, Turpin J, Lhote R, Cassar O, et al
    Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion.
    Int J Hematol. 2017 Jan 30. doi: 10.1007/s12185-016-2174.
    PubMed     Text format     Abstract available


  92. ANDO T, Yamazaki E, Ogusa E, Ishii Y, et al
    Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
    Int J Hematol. 2017 Jan 21. doi: 10.1007/s12185-017-2183.
    PubMed     Text format     Abstract available


  93. IWASA M, Miura Y, Fujishiro A, Fujii S, et al
    Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Int J Hematol. 2017 Jan 2. doi: 10.1007/s12185-016-2169.
    PubMed     Text format     Abstract available


  94. WAISBREN J, Dinner S, Altman J, Frankfurt O, et al
    Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia.
    Int J Hematol. 2017;105:44-51.
    PubMed     Text format     Abstract available


    December 2016
  95. SHIMOMURA Y, Maruoka H, Ishikawa T
    Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.
    Int J Hematol. 2016 Dec 20. doi: 10.1007/s12185-016-2167.
    PubMed     Text format     Abstract available


  96. ISMAIL MM, Abdulateef NA
    Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  97. MORITA M, Nishinaka Y, Kato I, Saida S, et al
    Dasatinib induces autophagy in mice with Bcr-Abl-positive leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  98. HAJI S, Shiratsuchi M, Matsushima T, Takamatsu A, et al
    Achievement of disease control with donor-derived EB virus-specific cytotoxic T cells after allogeneic peripheral blood stem cell transplantation for aggressive NK-cell leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  99. UEMURA M, Imataki O, Kawachi Y, Kawakami K, et al
    Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.
    Int J Hematol. 2016;104:621-627.
    PubMed     Text format     Abstract available


  100. JUNG KS, Cho SH, Kim SJ, Ko YH, et al
    Clinical features and treatment outcome of Epstein-Barr virus-positive nodal T-cell lymphoma.
    Int J Hematol. 2016;104:591-595.
    PubMed     Text format     Abstract available


  101. RUBIO P, Campos B, Digiorge JA, Gallego MS, et al
    NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value.
    Int J Hematol. 2016;104:582-590.
    PubMed     Text format     Abstract available


  102. MONIKA BELICKOVA M, Merkerova MD, Votavova H, Valka J, et al
    Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms.
    Int J Hematol. 2016;104:566-573.
    PubMed     Text format     Abstract available


    October 2016
  103. YANG W, Ernst P
    SET/MLL family proteins in hematopoiesis and leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  104. MAZUMDAR C, Majeti R
    The role of mutations in the cohesin complex in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  105. SUKNUNTHA K, Thita T, Togarrati PP, Ratanachamnong P, et al
    Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  106. BADAT M, Oyesanya F, Cervi P
    CLL with intra-cytoplasmic lymphocytic inclusion bodies.
    Int J Hematol. 2016;104:411-2.
    PubMed     Text format    


    September 2016
  107. KAWAMOTO S, Yamamoto K, Toyoda M, Yakushijin K, et al
    Constitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  108. TANAHASHI T, Sekiguchi N, Matsuda K, Matsumoto A, et al
    A screening method with lymphocyte percentage and proportion of granular lymphocytes in the peripheral blood for large granular lymphocyte (LGL) leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  109. TSUBOKURA Y, Satake A, Hotta M, Yoshimura H, et al
    Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  110. SAKAMOTO K, Tanaka S, Tomoyasu C, Tomii T, et al
    Development of acute lymphoblastic leukemia with IgH-EPOR in a patient with secondary erythrocytosis.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  111. OGIYA D, Matsushita H, Murayama H, Ando K, et al
    Chediak-Higashi-like granules and waxy Auer bodies in a case of acute promyelocytic leukemia.
    Int J Hematol. 2016.
    PubMed     Text format    


  112. YAMAMOTO K, Minami Y, Kawamoto S, Yakushijin K, et al
    Sea-blue histiocytes in acute myeloid leukemia with trisomy 9.
    Int J Hematol. 2016.
    PubMed     Text format    


  113. LAM YM, Chan YF, Chan LC, Ng RK, et al
    Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  114. HINO A, Yoshida H, Tada Y, Koike M, et al
    Changes from imatinib mesylate to second generation tyrosine kinase inhibitors improve renal impairment with imatinib mesylate in chronic myelogenous leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  115. ICHIKAWA K, Edahiro Y, Gotoh A, Iiduka K, et al
    Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  116. KWON JH, Koh YI, Yoon SS, Park S, et al
    Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  117. KUTLAY NY, Pekpak E, Altiner S, Ileri T, et al
    Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  118. AOKI S, Firouzi S, Lopez Y, Yamochi T, et al
    Transition of adult T-cell leukemia/lymphoma clones during clinical progression.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  119. DAVILA ML, Sadelain M
    Biology and clinical application of CAR T cells for B cell malignancies.
    Int J Hematol. 2016;104:6-17.
    PubMed     Text format     Abstract available


    June 2016
  120. NISHI Y, Fukushima T, Nomura S, Tomoyose T, et al
    Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  121. ZHANG X, Tu H, Yang Y, Wan Q, et al
    High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  122. KURIYAMA T, Kawano N, Yamashita K, Kikuchi I, et al
    Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  123. OSHIMA Y, Yuji K, Tojo A
    "Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report database.
    Int J Hematol. 2016;103:596-8.
    PubMed     Text format    


  124. GARG S, Ghosh K, Madkaikar M
    Antigen expression on a putative leukemic stem cell population and AML blast.
    Int J Hematol. 2016;103:567-71.
    PubMed     Text format     Abstract available


  125. WANG X, Chu Y, Wang W, Yuan W, et al
    mTORC signaling in hematopoiesis.
    Int J Hematol. 2016;103:510-8.
    PubMed     Text format     Abstract available


    April 2016
  126. KOH K, Ogawa C, Okamoto Y, Kudo K, et al
    Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  127. AMMATUNA E
    Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia: should this be the first choice to establish the diagnosis of APL?
    Int J Hematol. 2016.
    PubMed     Text format    


  128. HARADA M, Gale RP
    Commentary: How do haematopoietic cell transplants cure leukaemia?
    Int J Hematol. 2016;103:396-8.
    PubMed     Text format    


  129. MANABE A
    Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Int J Hematol. 2016;103:359.
    PubMed     Text format    


  130. SCHALK E, Heidel FH
    Leukemic mastopathy.
    Int J Hematol. 2016;103:357-8.
    PubMed     Text format    


    March 2016
  131. SARASHINA T, Iwabuchi H, Miyagawa N, Sekimizu M, et al
    Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  132. LIU L, Yuan X
    Transient ischemic attack as an unusual initial manifestation of acute promyelocytic leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  133. ZHU H, Xu W, Liu H, Wang H, et al
    Expression of activated molecules on CD5B lymphocytes in autoimmune hemolytic anemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  134. SHIGEMURA T, Nishina S, Nakazawa H, Matsuda K, et al
    Early detection of Rhizopus DNA in the serum of a patient with rhino-orbital-cerebral mucormycosis following allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2016;103:354-5.
    PubMed     Text format    


    February 2016
  135. SAIDA S
    Evolution of myeloid leukemia in children with Down syndrome.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  136. JIANG Y, Nakada D
    Cell intrinsic and extrinsic regulation of leukemia cell metabolism.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  137. GOTO S, Goto H, Yokosuka T
    The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  138. KATAGIRI S, Gotoh M, Tone K, Akahane D, et al
    Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  139. OTSUKA Y, Kondo T, Nakamoto Y, Haga H, et al
    18F-FDG PET/CT and MRI findings in a case of granulocytic sarcoma of the breast.
    Int J Hematol. 2016;103:117-8.
    PubMed     Text format    


  140. MITSUI T, Koiso H, Nakahashi H, Saitoh A, et al
    SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.
    Int J Hematol. 2016;103:219-26.
    PubMed     Text format     Abstract available


  141. CHAVDA S, Liapis K
    Detection of mycobacteria in MGG-stained bone marrow smears.
    Int J Hematol. 2016;103:115-6.
    PubMed     Text format    


    January 2016
  142. SUBARI S, Baidoun F, Hreh M, Patnaik M, et al
    Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  143. YANADA M, Yamamoto Y, Iba S, Okamoto A, et al
    TP53 mutations in older adults with acute myeloid leukemia.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  144. KEINO D, Kinoshita A, Tomizawa D, Takahashi H, et al
    Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  145. CHEN Z, Li Y, Tong Y, Gao Q, et al
    Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry.
    Int J Hematol. 2016.
    PubMed     Text format     Abstract available


  146. HIRADE T, Abe M, Onishi C, Taketani T, et al
    Internal tandem duplication of FLT3 deregulates proliferation and differentiation and confers resistance to the FLT3 inhibitor AC220 by Up-regulating RUNX1 expression in hematopoietic cells.
    Int J Hematol. 2016;103:95-106.
    PubMed     Text format     Abstract available


    December 2015
  147. NAKAMURA Y, Tokita K, Nagasawa F, Takahashi W, et al
    Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  148. MOHREN M, Jentsch-Ullrich K, Koenigsmann M, Kropf S, et al
    High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  149. OKAMOTO Y, Koga Y, Inagaki J, Ozono S, et al
    Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


  150. YANAGISAWA R, Nakazawa Y, Sakashita K, Saito S, et al
    Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  151. NOMOTO H, Takami A, Espinoza JL, Matsuo K, et al
    A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.
    Int J Hematol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  152. MICHELIS FV, Bril V, Lipton JH
    A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Int J Hematol. 2015;102:144-6.
    PubMed     Text format     Abstract available


  153. HOUWING ME, Koopman-Coenen EA, Kersseboom R, Gooskens S, et al
    Somatic thrombopoietin (THPO) gene mutations in childhood myeloid leukemias.
    Int J Hematol. 2015;102:140-3.
    PubMed     Text format     Abstract available


    June 2015
  154. SREEDHARANUNNI S, Varma N, Sachdeva MU, Gupta K, et al
    CD103+ gammadelta T cell large granular lymphocytosis in a patient with refractory celiac disease: a diagnostic enigma.
    Int J Hematol. 2015;101:603-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: